Xiaoshuo Dai

Henan Province 450001, PR China
Puerto Rico

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Diosmetin alleviates the immunosuppressive tumor microenvironment in esophageal squamous cell carcinoma by dually inhibiting angiogenesis and promoting CD8+T cell cytotoxicity.

Diosmetin alleviates the immunosuppressive tumor microenvironment in esophageal squamous cell carcinoma by dually inhibiting angiogenesis and promoting CD8+T cell cytotoxicity.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: December 19, 2025

Current advances and clinical perspectives of anti-angiogenic therapy combined with immune checkpoint inhibitors in digestive system malignancies.

Current advances and clinical perspectives of anti-angiogenic therapy combined with immune checkpoint inhibitors in digestive system malignancies.

Journal: Biochimica et biophysica acta. Reviews on cancer

Published: November 21, 2025

Fatty acid metabolic reprogramming in gastrointestinal tumor microenvironment: Emerging mechanisms and therapeutic opportunities.

Fatty acid metabolic reprogramming in gastrointestinal tumor microenvironment: Emerging mechanisms and therapeutic opportunities.

Journal: Critical reviews in oncology/hematology

Published: November 04, 2025

JAK3/STAT5A-dependent IL-8 regulation drives ESCC angiogenesis and is suppressed by dihydroartemisinin.

JAK3/STAT5A-dependent IL-8 regulation drives ESCC angiogenesis and is suppressed by dihydroartemisinin.

Journal: International immunopharmacology

Published: April 10, 2025

Selection and identification of DNA aptamer binding VDAC1 for tumor tissue imaging and targeted drug delivery.

Selection and identification of DNA aptamer binding VDAC1 for tumor tissue imaging and targeted drug delivery.

Journal: International journal of biological macromolecules

Published: December 25, 2024

KNTC1 functions as a potential biomarker and oncogene regulating proliferation, migration and apoptosis in gastric cancer.

KNTC1 functions as a potential biomarker and oncogene regulating proliferation, migration and apoptosis in gastric cancer.

Journal: International immunopharmacology

Published: May 10, 2024

Deciphering JAK/STAT signaling pathway: A multifaceted approach to tumorigenesis, progression and therapeutic interventions.

Deciphering JAK/STAT signaling pathway: A multifaceted approach to tumorigenesis, progression and therapeutic interventions.

Journal: International immunopharmacology

Published: January 14, 2024

Dihydroartemisinin inhibits the development of colorectal cancer by GSK-3β/TCF7/MMP9 pathway and synergies with capecitabine.

Dihydroartemisinin inhibits the development of colorectal cancer by GSK-3β/TCF7/MMP9 pathway and synergies with capecitabine.

Journal: Cancer letters

Published: July 17, 2023

PHGDH promotes esophageal squamous cell carcinoma progression via Wnt/β-catenin pathway.

PHGDH promotes esophageal squamous cell carcinoma progression via Wnt/β-catenin pathway.

Journal: Cellular signalling

Published: February 23, 2023

Joint analysis identified FAP as a prognostic and diagnostic biomarker correlated immune infiltration in gastric cancer.

Joint analysis identified FAP as a prognostic and diagnostic biomarker correlated immune infiltration in gastric cancer.

Journal: Pathology, research and practice

Published: November 03, 2022

PGC-1α promotes colorectal carcinoma metastasis through regulating ABCA1 transcription.

PGC-1α promotes colorectal carcinoma metastasis through regulating ABCA1 transcription.

Journal: Oncogene

Published: October 21, 2022

Diosmetin suppresses the progression of ESCC by CDK2/Rb/E2F2/RRM2 pathway and synergies with cisplatin.

Diosmetin suppresses the progression of ESCC by CDK2/Rb/E2F2/RRM2 pathway and synergies with cisplatin.

Journal: Oncogene

Published: September 06, 2022

Showing 1-12 of 18

Last Updated: 09/26/2026